Risks and Outcomes of Early Dose Reduction in Adjuvant CAPOX Therapy for Colorectal Cancer.
Shioi I, Ogawa H, Naito R, Endo M, Hosoi N, Tateno K, Uchida S, Yamaguchi A, Watanabe T, Nakazawa N, Shibasaki Y, Komine C, Shiraishi T, Osone K, Okada T, Sano A, Sakai M, Sohda M, Shirabe K, Saeki H.
Shioi I, et al. Among authors: shibasaki y.
Anticancer Res. 2024 Jul;44(7):3013-3023. doi: 10.21873/anticanres.17114.
Anticancer Res. 2024.
PMID: 38925838